Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Better Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 36,913 | $6.27 K | $0.17 | May 27, 2022 | Direct |
Better Therapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 43,626 | May 27, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BTTX | Better Therapeutics, Inc. | May 27, 2022 | 2 | 839 | 4 | Jun 1, 2022 | Chief Commercial Officer |
BTTX | Better Therapeutics, Inc. | May 16, 2022 | 2 | 17,618 | 4 | May 18, 2022 | Chief Commercial Officer |
BTTX | Better Therapeutics, Inc. | Apr 1, 2022 | 1 | 0 | 4 | Apr 4, 2022 | Chief Commercial Officer |
BTTX | Better Therapeutics, Inc. | Oct 28, 2021 | 0 | 0 | 3 | Nov 1, 2021 | Chief Commercial Officer |